Note: We are no longer accepting Stryker Orthopedics Hip Implant cases.
Hip implant products “Rejuvenate” and “ABG II” by medical manufacturer Stryker Orthopedics (also known as Howmedica Osteonics) have now been recalled. An astounding number of patients have undergone hip joint surgery only to discover that they need to have the defective product removed and replaced with additional arthroplasty.
The “Rejuvenate” and “ABG II” are modular-neck stems used during hip arthroplasty that were voluntarily recalled in August 2012 by the manufacturer Stryker Orthopaedics. While the manufacturer is New Jersey based, more and more victims are coming forward nationally.
What are the side effects of the “Rejuvenate” and “ABG II” hip implants?
Scientific evidence concludes that the metal stem in models “Rejuvenate” and “ABG II” are susceptible to corroding and fretting which can lead to metal ion deposits in the surrounding soft tissue. The products are not metal-on-metal devices like the recalled Johnson & Johnson’s DePuy ASR product, however, they still pose a risk for metal ion build up. The increased levels of chromium ions and cobalt in the bloodstream can be a toxic combination leading to adverse reactions. The adverse reactions include bone dissolution, pseudo tumors, necrosis (death) of skin tissue, bone and muscle and inflammation of the synovial membrane which are all issues that can cause additional bodily harm, pain, swelling and further health complications.
Hip arthroplasty can be a painful surgical process the first time, and the additional required revisional surgery to remove and replace the defective product can be a painful and costly process requiring a long recovery time.
How serious is the hip implant product recall?
If you have received a “Rejuvenate” or “ABG II” hip implant it is important to note that the recall is an urgent safety alert from the FDA. You can find out which stem part of your hip implant product was used during your surgery by contacting your surgeon. It may be a possibility that your surgery has included “Rejuvenate” product because the line has been on the market since its approval in 2008.
About Sanders Phillips Grossman
Sanders Phillips Grossman has been holding pharmaceutical companies responsible for injuring individuals by their defective drugs and devices for over 30 years. Defective drugs are pharmaceuticals with side effects that potentially harm, injure, or kill the patient to the point that they outweigh the drug’s intended benefits. Defective devices, such as faulty prosthetics, implants, pacemakers, or surgical instruments can harm patients when the product is defective in the manufacturing process, design, or marketing strategy.
Pharmaceutical companies are some of the largest, wealthiest, and most influential corporate entities in the world. Sanders Phillips Grossman and its predecessors have recovered over one billion dollars for injured consumers. Our firm’s history in dealing with drug and medical device injury claims has allowed us to take leadership roles in many of the national defective drug and device litigations.
Nationally recognized as a leading plaintiff’s law firm, we handle cases in all 50 states and Puerto Rico.
Read more about our attorneys here.